Can-Fite BioPharma Ltd. Sponsored ADR
(NYSE Amex Equities : CANF)

( )
CANF PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.12%196.411.2%$567.51m
TSROTESARO, Inc.
0.08%74.3114.4%$551.02m
CELGCelgene Corporation
2.03%70.901.2%$541.17m
GILDGilead Sciences, Inc.
0.62%68.140.9%$521.04m
BIIBBiogen Inc.
0.88%322.611.3%$364.53m
ILMNIllumina, Inc.
2.44%336.923.5%$356.07m
REGNRegeneron Pharmaceuticals, Inc.
0.60%377.962.6%$267.70m
AAgilent Technologies, Inc.
0.99%71.751.5%$240.96m
VRTXVertex Pharmaceuticals Incorporated
1.28%175.451.9%$234.92m
ALXNAlexion Pharmaceuticals, Inc.
1.90%117.012.0%$146.65m
SRPTSarepta Therapeutics, Inc.
0.10%125.1315.4%$110.90m
INCYIncyte Corporation
3.16%67.672.5%$104.86m
EXASExact Sciences Corporation
3.27%71.7925.3%$97.81m
NKTRNektar Therapeutics
1.48%36.975.5%$91.00m
SGENSeattle Genetics, Inc.
1.66%61.956.6%$85.00m

Company Profile

Can-Fite BioPharma Ltd. operates as a clinical-stage biopharmaceutical company, which focuses on developing orally bioavailable small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological and ophthalmic diseases. Its products include pipeline drugs such as CF101, CF102 and CF602. The company offers drugs for the treatment of Psoriasis, Rheumatic Arthritis, Glaucoma, Uveitis, Crohn's disease, Osteoathritis, Hepatitis C, and Liver Cancer. Can-Fite BioPharma was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach Tikva, Israel.